Q-Med is a medical device Group that primarily develops, manufactures, markets and sells medical implants.
Q-Med develops products that improve the appearance. When someone experiences a heightened sense of well-being, greater self-esteem or a greater quality of life with the aid of our products, that is beauty for us.
Several of Q-Med's products have been the first on the market. Most of the products are based on the company's patented technology, NASHA, for the production of stabilized non-animal hyaluronic acid.
The company today has approximately 650 co-workers in 20 countries, with almost 400 at the company's head office and production facility in Uppsala. Q-Med AB is listed in the Mid Cap segment of the NASDAQ OMX Nordic.
Okuloplastische Chirurgie
Donnerstag, 7. Juni 2012, 9:00–17:00 Uhr
Freitag, 8. Juni 2012, 8:00–14:30 Uhr